A prospective randomized trial comparing endarterectomy to stenting in severe asymptomatic carotid stenosis

Dallit Mannheim1, Ron Karmeli2

  • 1Department of Vascular Surgery, Carmel Medical Center, Haifa, Israel - dallit@gmail.com.

Insights

Carotid artery stenting (CAS) and carotid endarterectomy (CEA) showed similar outcomes for preventing stroke in asymptomatic patients with severe carotid stenosis. Both procedures demonstrated comparable safety and long-term effectiveness in this patient group.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Interventional Cardiology

Background:

  • Severe carotid stenosis is a significant risk factor for ischemic stroke.
  • Over 50% of carotid stenosis procedures are performed on asymptomatic patients.
  • Limited randomized trials specifically compare carotid endarterectomy (CEA) and stenting (CAS) in asymptomatic individuals.

Purpose of the Study:

  • To compare the periprocedural complications and long-term results of CEA and CAS in asymptomatic patients with severe carotid stenosis.
  • To evaluate stroke (CVA), transient ischemic attack (TIA), myocardial infarction (MI), and mortality rates.
  • To assess long-term outcomes including mortality, ipsilateral stroke/TIA prevention, and restenosis rates.

Main Methods:

  • Prospective randomized controlled trial (1:1 allocation) comparing CEA and CAS.
  • Inclusion criteria: asymptomatic patients with >70% carotid artery stenosis eligible for both procedures.
  • Primary endpoints: periprocedural complications (CVA, TIA, MI, death) and long-term results (mortality, stroke/TIA, restenosis).

Main Results:

  • 136 patients were randomized with a mean follow-up of 26 months.
  • No significant difference in short-term or long-term outcomes between CEA and CAS groups.
  • 30-day morbidity: 1 CVA per group, no MI. Long-term: 4 deaths per group (none from CVA), 1 TIA post-CAS, 3 restenosis post-CEA vs. 1 post-CAS.

Conclusions:

  • Carotid artery stenting (CAS) is a viable and maturing alternative to carotid endarterectomy (CEA) for selected asymptomatic patients.
  • Both procedures demonstrate comparable safety and efficacy in preventing stroke and long-term complications.
  • Advancements in CAS technology may further improve perioperative results, supporting its increased use.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
438
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
512
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
373
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
423